Matrix Capital Management Company
Latest statistics and disclosures from Matrix Capital Management Company's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NVDA, GFS, AMAT, AMZN, TDG, and represent 62.38% of Matrix Capital Management Company's stock portfolio.
- Added to shares of these 4 stocks: MRVL (+$251M), ADSK (+$61M), SNPS (+$50M), ALTR (+$7.9M).
- Matrix Capital Management Company was a net buyer of stock by $369M.
- Matrix Capital Management Company has $8.3B in assets under management (AUM), dropping by -3.14%.
- Central Index Key (CIK): 0001410830
Tip: Access up to 7 years of quarterly data
Positions held by Matrix Capital Management Company consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Matrix Capital Management Company
Matrix Capital Management Company holds 19 positions in its portfolio as reported in the September 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
NVIDIA Corporation (NVDA) | 16.5 | $1.4B | 3.2M | 434.99 |
|
|
Globalfoundries Ordinary Shares (GFS) | 11.9 | $992M | 17M | 58.19 |
|
|
Applied Materials (AMAT) | 11.7 | $976M | 7.1M | 138.45 |
|
|
Amazon (AMZN) | 11.2 | $933M | 7.3M | 127.12 |
|
|
TransDigm Group Incorporated (TDG) | 11.1 | $923M | 1.1M | 843.13 |
|
|
Marvell Technology (MRVL) | 8.5 | $713M | +54% | 13M | 54.13 |
|
Altair Engr Com Cl A (ALTR) | 8.5 | $707M | 11M | 62.56 |
|
|
Workday Cl A (WDAY) | 4.1 | $341M | 1.6M | 214.85 |
|
|
Synopsys (SNPS) | 4.0 | $329M | +17% | 718k | 458.97 |
|
Asml Holding N V N Y Registry Shs (ASML) | 3.5 | $293M | 497k | 588.66 |
|
|
Zentalis Pharmaceuticals (ZNTL) | 3.4 | $280M | 14M | 20.06 |
|
|
Qualcomm (QCOM) | 2.5 | $207M | 1.9M | 111.06 |
|
|
Autodesk (ADSK) | 1.0 | $86M | +247% | 414k | 206.91 |
|
Adaptive Biotechnologies Cor (ADPT) | 0.8 | $63M | 12M | 5.45 |
|
|
Aura Biosciences (AURA) | 0.6 | $48M | 5.4M | 8.97 |
|
|
Perimeter Solutions Sa Common Stock (PRM) | 0.4 | $34M | 7.5M | 4.54 |
|
|
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.4 | $30M | 39M | 0.78 |
|
|
Ventyx Biosciences (VTYX) | 0.0 | $3.1M | 90k | 34.73 |
|
|
Zscaler Incorporated (ZS) | 0.0 | $2.9M | 18k | 155.59 |
|
Past Filings by Matrix Capital Management Company
SEC 13F filings are viewable for Matrix Capital Management Company going back to 2010
- Matrix Capital Management Company 2023 Q3 filed Nov. 14, 2023
- Matrix Capital Management Company 2023 Q2 filed Aug. 14, 2023
- Matrix Capital Management Company 2023 Q1 filed May 15, 2023
- Matrix Capital Management Company 2022 Q4 filed Feb. 13, 2023
- Matrix Capital Management Company 2022 Q3 filed Nov. 14, 2022
- Matrix Capital Management Company 2022 Q2 filed Aug. 15, 2022
- Matrix Capital Management Company 2022 Q1 filed May 16, 2022
- Matrix Capital Management Company 2021 Q4 filed Feb. 15, 2022
- Matrix Capital Management Company 2021 Q3 filed Nov. 15, 2021
- Matrix Capital Management Company 2021 Q2 filed Aug. 16, 2021
- Matrix Capital Management Company 2021 Q1 filed May 17, 2021
- Matrix Capital Management Company 2020 Q4 filed Feb. 16, 2021
- Matrix Capital Management Company 2020 Q3 filed Nov. 16, 2020
- Matrix Capital Management Company 2020 Q2 filed Aug. 14, 2020
- Matrix Capital Management Company 2020 Q1 filed May 15, 2020
- Matrix Capital Management Company 2019 Q4 filed Feb. 14, 2020